• 2001 6thSt. SE, Mail Code 2873, McGuire Translational Research Institute

    55455 Minneapolis

    United States

Organization profile

Organization profile

Scientists at the UMN Stem Cell Institute study the basic biology of how stem cells work. The SCI faculty works in collaboration with many other areas in the University to lay the foundation for safe and effective treatments using stem cells. Scientists at the SCI performs research and do not treat patients directly. We bring together talent and expertise from across the University of Minnesota to use stem cell biology to advance regenerative medicine therapies for devastating disorders and to provide education and training for the stem cell scientists of tomorrow.

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Genes Medicine & Life Sciences
Stem Cells Medicine & Life Sciences
Transplants Medicine & Life Sciences
Transplantation Medicine & Life Sciences
Fetal Blood Medicine & Life Sciences
Proteins Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Cell Transplantation Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1997 2024

Fetal Blood
Stem Cells
Hematologic Neoplasms
Blood Cells
Stem Cell Transplantation
Stem Cells
Cord Blood Stem Cell Transplantation
Hematologic Neoplasms

Research Output 1995 2017

Aryl hydrocarbon receptor inhibition promotes hematolymphoid development from human pluripotent stem cells

Angelos, M. G., Ruh, P. N., Webber, B. R., Blum, R. H., Ryan, C. D., Bendzick, L., Shim, S., Yingst, A. M., Tufa, D. M., Verneris, M. R. & Kaufman, D. S. Jun 29 2017 In : Blood. 129, 26, p. 3428-3439 12 p.

Research output: Contribution to journalArticle

Aryl Hydrocarbon Receptors
Pluripotent Stem Cells
Human Development
Inhibition (Psychology)
Status Epilepticus
3 Citations

A subset of virus-specific CD161+ T cells selectively express the multidrug transporter MDR1 and are resistant to chemotherapy in AML

Alsuliman, A., Muftuoglu, M., Khoder, A., Ahn, Y. O., Basar, R., Verneris, M. R., Muranski, P., Barrett, A. J., Liu, E., Li, L., Stringaris, K., Armstrong-James, D., Shaim, H., Kondo, K., Imahashi, N., Andersson, B., Marin, D., Champlin, R. E., Shpall, E. J. & Rezvani, K. Feb 9 2017 In : Blood. 129, 6, p. 740-758 19 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Drug Therapy
Hematologic Neoplasms
Blood Donors
Fetal Blood
Dendritic Cells